Tissue inhibitor of metalloproteinase type three (TIMP-3)...

Details Tissue inhibitor of metalloproteinase type three (TIMP-3)... Tissue inhibitor of metalloproteinase type three (TIMP-3)...

2006-07-04

2006-07-04

Martinell, James (Department: 1634)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S023100

Reexamination Certificate

active

07071317

ABSTRACT:
The present invention relates in general to metalloproteinase inhibitors and to polynucleotides encoding such inhibitors. In particular, the invention relates to novel mammalian inhibitors of metalloproteinase, which are designated as type three or TIMP-3, to fragments, derivatives, and analogs thereof, and to polynucleotides encoding the same. Novel methods of producing such compositions and novel methods of using such compositions are also provided.

REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 4710473 (1987-12-01), Morris
patent: 5595885 (1997-01-01), Stetler-Stevenson et al.
patent: 0398 753 (1990-11-01), None
patent: 91/05795 (1991-05-01), None
Orkin et al “Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy,” Dec. 7, 1995, National Institutes of Health, Bethesda, MD.
Pavloff et al, J. Biol. Chem. 267: 17321 (1992).
Wallace et al, Methods Enzymol. 152: 432 (1987).
Apte et al., Chemical Abst. 121: Abst. No. 197175 (1994).
Apte et al., Genomics 19: 86-90 (1994).
Herron et al., J. Biol. Chem. 261: 2814-2818 (1986).
Kishnani et al., FASEB J. 7: A371 (Feb. 1993).
Leco et al., J. Biol. Chem. 269: 9352-9360 (1994).
Stetler-Stevenson et al., J. Biol. Chem. 265: 13933-13938 (1990).
Apodaca et al., Cancer Res. 50: 2322-2329 (1990).
Silbiger et al., Gene 141: 293-297 (1994).
Uria et al., Cancer Research 54: 2091-2094 (1994).
Banda et al., Biochem. J. 193: 589-605 (1981).
Baron et al., Cell 28: 395-404 (1982).
Bauer et al., J. Exp. Med. 148: 1378-1387 (1978).
Boone et al., Proc. Natl. Acad. Sci. USA 87: 2800-2804 (1990).
Branstrom et al., Endocrinology 122: 1715-1721 (1988).
Brown et al., American J. of Ophthalmology 72: 1139-1142 (1971).
Carlos et al., Immunol. Rev. 114: 5-28 (1990).
Carmichael et al., Proc. Natl. Acad. Sci. USA 83: 2407-2411 (1986).
Cawston et al., J. Biochem. 211: 313-318 (1983).
Chomczynski et al., Anal. Biochem. 162: 156-159 (1987).
Collier et al., Genomics 9: 429-434 (1991).
D'Armiento et al., Cell 71: 955-961 (1992).
Madshus et al., J. Biol. Chem. 266: 17446-17453 (1991).
DeClerck et al., Cancer Research 46: 3580-3586 (1986).
Docherty et al., Nature 318: 66-69 (1985).
Dressman et al., Nature 295: 158-160 (1982).
Edwards et al., Nucleic Acid. Res. 14: 8863-8878 (1986).
Evanson et al., J. Clin. Invest. 47: 2639-2651 (1968).
Freudenstein et al., Biochem. Biophys. Res. Comm. 171: 250-256 (1990).
Friedman et al., Nucl. Acids Res. 16: 8718 (1988).
Gewert et al., EMBO J. 6: 651-657 (1987).
Glorieux et al., Cancer 58: 2136-2139 (1986).
Goldberg, G.I., J. Biol. Chem. 261: 6600-6605 (1986).
Graeve et al., Cancer 62: 2125-2127 (1988).
Grivskov et al., Nucl. Acids Res. 14: 6745-6763 (1986).
Hewick et al., J. Biol. Chem. 256: 7990-7997 (1981).
Hibbs et al., J. Biol. Chem. 260: 2493-2500 (1985).
Hicks et al., Int. J. Cancer 33: 835-844 (1984).
Horowitz et al., J. Biol. Chem. 264: 7092-7095 (1989).
Huse et al., Science 246: 1275-1281 (1989).
Johnson et al., Mol. Cell. Biol. 7: 2821-2829 (1987).
Kaiser et al., Science 223: 249-255 (1984).
Khokho et al., Science 243: 947-950 (1989).
Kohler et al., Eur. J. Immunol. 6: 511-519 (1976).
Lerner et al., Cell 23: 309-310 (1981).
Lerner et al., Proc. Natl. Acad. Sci. USA 78: 3403-3407 (1981).
Lerner et al., Scientific Am. 248: 66-74 (1983).
Liotta et al., Biochem. Biophys. Res. Commun. 98: 184-198 (1981).
Liotta et al., Nature 284: 67-68 (1980).
Liotta et al., Proc. Natl. Acad. Sci. USA 76: 2268-2272 (1979).
Matrisian, Trends in Genetics 6: 121-125 (1990).
McCartney et al., Eur. J. Biochem. 130: 79-83 (1983).
Murphy et al., Biochem. J. 203: 209-221 (1982).
Murphy et al., Biochem, J. 195: 167-170 (1981).
Murray et al., J. Biol. Chem. 261: 4154-4159 (1986).
Palmiter et al., Science 222: 809-814 (1983).
Pisko et al., J. Immunol. 136: 2141-2150 (1986).
Remington's Pharmaceutical Sciences, 18thEd. (1990, Mack Publishing Co., Easton, PA 18042) pp. 697-773.
Ross et al., Nature 294: 654-656 (1981).
Salo et al., J. Biol. Chem. 258: 3058-3063 (1983).
Schultz et al., Cancer Research 48: 5539-5545 (1988).
Shimizu et al., Gene 114: 291-292 (1992).
Slansky et al., Annals of Ophthalmology 2: 488-491 (1970).
Staskus et al., J. Biol. Chem. 266: 449-454 (1991).
Stetler-Stevenson et al., J. Biol. Chem. 264: 17374-17378 (1989).
Stricklin et al., J. Biol. Chem. 258: 12252-12258 (1983).
Tartof and Hobbs, Bethesda Res. Lab. Focus 9: 12 (1987).
Thorgeirsson et al., J. Natl. Canc. Inst. 69: 1049-1054 (1982).
Tolley et al., J. Mol. Biol. 229: 1163-1164 (1993).
Tramontano et al., Nucl. Acid Res. 12: 5049-5059 (1984).
V.J. Uitto, pp. 211-223 inProteinases In Inflammation and Tumor Invasion, H. Tschesche, ed., Walter de Gruyter & Co., Berlin, N.Y. (1988).
Van Ranst et al., Cytokine 3: 231-239 (1991).
Verma, Scientific Am., Nov. 68-84 (1990).
Walter et al., Proc. Natl. Acad. Sci. USA 77: 5197-5200 (1980).
Walter et al., Proc. Natl. Acad. Sci. USA 78: 4882-4886 (1981).
Weiland et al., Blut 44: 173-175 (1982).
Werb et al., J. Exp. Med. 142: 346-360 (1975).
Willenbrock et al., Biochemistry 32: 4330-4337 (1993).
Nigg et al., Proc. Natl. Acad. Sci. USA 79: 5322-5326 (1982).
Woolley et al., Arthritis and Rheumatism 20: 1231-1239 (1977).
Yang et al., Proc. Natl. Acad. Sci. USA 89: 10676-10680 (1992).
Cocuzzi et al., FEBS Letters 307: 375-378 (1992).
Jones et al., FEBS Letters 352: 171-174 (1994).
Vincenti et al., Arthritis and Rheumatism 37: 1115-1126 (1994).
Zucker et al., Int. J. Cancer 52: 366-371 (1992).

Affiliated with

Also associated with

Rating

Tissue inhibitor of metalloproteinase type three (TIMP-3)... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tissue inhibitor of metalloproteinase type three (TIMP-3)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue inhibitor of metalloproteinase type three (TIMP-3)... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3547223